Search Results 2241-2250 of 18907 for Relapse
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...
Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND. Hypo ...
The purpose of this study is to determine the safety and effectiveness of bb2121 (Ide-Cel) combinations in subjects with relapsed/refractory multiple myeloma.
Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...
The exact prevalence of imperforate anus in the newborn population is unknown. Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory ...
This medicine may also cause relapse in people with a history of substance abuse. Tell your doctor right away if you start to feel more depressed or exhibit ...
... relapsed blood cancers. While the results are impressive, not everyone ... treatments to manage the recurrence, as well as a second relapse 18 months ...
... relapse occurs within 3 months of stopping corticosteroids; OR. Has been intolerant to 1 or more of the above-mentioned treatments (eg, unable to achieve ...
tobacco users quit and residential treatment programs help with smoking relapse compared to standard outpatient treatment. The team is also using nicotine ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!